Paragard IUD Lawsuit Update 2026

February 2026 — First Bellwether: Teva Defense Verdict

The most significant development in Paragard litigation in 2026 was the February 5, 2026 defense verdict in Rickard v. Teva Pharmaceuticals — the first bellwether trial in MDL 2974. The jury found for Teva on all counts after a multi-week trial before Judge Leigh Martin May in Atlanta. Plaintiff Pauline Rickard alleged that her Paragard IUD broke during removal in 2018, requiring surgery, and that Teva failed to adequately warn of the fracture risk. Teva's defense argued that the labeling disclosed the breakage risk and that the provider's removal technique was a contributing factor. The verdict was immediately reported across legal news outlets and caused significant discussion among Paragard plaintiffs and their attorneys about the litigation's trajectory.

What Comes Next — March and May 2026 Bellwether Trials

Two additional bellwether trials are scheduled in 2026: one set for March 2026 and one for May 2026. These trials will present different plaintiffs with different fact patterns — likely selected to test injury profiles and damages theories that distinguish them from the Rickard case. If plaintiffs win one or both of the remaining bellwether trials, the litigation dynamic will shift significantly toward global settlement. Even if Teva wins additional bellwethers, the sheer volume of cases — nearly 4,000 — creates settlement pressure, as continued litigation is expensive for both sides. Paragard plaintiffs' attorneys are monitoring these trials closely and continuing to prepare individual cases for the most favorable resolution possible.

MDL 2974 Case Count and Key Figures

As of February 2026, approximately 3,867 cases are pending in MDL 2974 before Judge Leigh Martin May in the Northern District of Georgia (Atlanta). The MDL was formed in August 2020. Teva Pharmaceuticals USA, Inc. is the primary defendant; CooperSurgical, Inc. (Cooper Companies subsidiary) is a co-defendant on distribution and marketing theories, though design defect claims against CooperSurgical were narrowed by a 2025 court ruling. The plaintiffs' steering committee coordinates discovery and expert witness strategy for all MDL plaintiffs. Local counsel in Atlanta work alongside national mass tort firms to manage the litigation's substantial logistics.

Historical Context — MDL Defense Verdicts Don't Mean Game Over

Large MDLs routinely produce defense verdicts in early bellwether trials without collapsing. The 3M Combat Arms Earplug MDL — the largest MDL in U.S. history with over 300,000 cases — saw multiple defense verdicts early in its bellwether process before ultimately achieving a $6 billion global settlement in 2023. The Bayer Essure MDL similarly produced mixed bellwether results before substantial resolution. The Rickard defense verdict will inform how plaintiffs' counsel selects and presents the next bellwether cases, strengthening the fact patterns chosen and refining the expert testimony strategy. Paragard claimants should not interpret the Rickard outcome as a signal to abandon their claims. The litigation is at a critical inflection point, and the next two bellwether results will determine the pace and magnitude of resolution.